Exact Mass: 715.5750582000001

Exact Mass Matches: 715.5750582000001

Found 500 metabolites which its exact mass value is equals to given mass value 715.5750582000001, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

AS 1-5

2-Hydroxy-N-[(4E)-3-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadec-4-en-2-yl]hexadecanimidate

C40H77NO9 (715.5598032)


AS 1-5 is found in onion-family vegetables. AS 1-5 is a constituent of Allium sativum (garlic) bulbs. Constituent of Allium sativum (garlic) bulbs. AS 1-5 is found in garlic and onion-family vegetables.

   

PC(14:0/P-18:1(11Z))

trimethyl[2-({2-[(1Z,11Z)-octadeca-1,11-dien-1-yloxy]-3-(tetradecanoyloxy)propyl phosphonato}oxy)ethyl]azanium

C40H78NO7P (715.5515607999998)


PC(14:0/P-18:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(14:0/P-18:1(11Z)), in particular, consists of one chain of myristic acid at the C-1 position and one chain of plasmalogen 18:1n7 at the C-2 position. The myristic acid moiety is derived from nutmeg and butter, while the plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PC(14:0/P-18:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(14:0/P-18:1(11Z)), in particular, consists of one chain of myristic acid at the C-1 position and one chain of plasmalogen 18:1n7 at the C-2 position. The myristic acid moiety is derived from nutmeg and butter, while the plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PC(14:0/P-18:1(9Z))

trimethyl[2-({2-[(1Z,9Z)-octadeca-1,9-dien-1-yloxy]-3-(tetradecanoyloxy)propyl phosphonato}oxy)ethyl]azanium

C40H78NO7P (715.5515607999998)


PC(14:0/P-18:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(14:0/P-18:1(9Z)), in particular, consists of one chain of myristic acid at the C-1 position and one chain of plasmalogen 18:1n9 at the C-2 position. The myristic acid moiety is derived from nutmeg and butter, while the plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PC(14:0/P-18:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(14:0/P-18:1(9Z)), in particular, consists of one chain of myristic acid at the C-1 position and one chain of plasmalogen 18:1n9 at the C-2 position. The myristic acid moiety is derived from nutmeg and butter, while the plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PC(14:1(9Z)/P-18:0)

trimethyl[2-({2-[(1Z)-octadec-1-en-1-yloxy]-3-[(9Z)-tetradec-9-enoyloxy]propyl phosphonato}oxy)ethyl]azanium

C40H78NO7P (715.5515607999998)


PC(14:1(9Z)/P-18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(14:1(9Z)/P-18:0), in particular, consists of one chain of myristoleic acid at the C-1 position and one chain of plasmalogen 18:0 at the C-2 position. The myristoleic acid moiety is derived from milk fats, while the plasmalogen 18:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

   

PC(16:1(9Z)/P-16:0)

[2-({2-[(1Z)-hexadec-1-en-1-yloxy]-3-[(9Z)-hexadec-9-enoyloxy]propyl phosphonato}oxy)ethyl]trimethylazanium

C40H78NO7P (715.5515607999998)


PC(16:1(9Z)/P-16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(16:1(9Z)/P-16:0), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of plasmalogen 16:0 at the C-2 position. The palmitoleic acid moiety is derived from animal fats and vegetable oils, while the plasmalogen 16:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PC(16:1(9Z)/P-16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(16:1(9Z)/P-16:0), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of plasmalogen 16:0 at the C-2 position. The palmitoleic acid moiety is derived from animal fats and vegetable oils, while the plasmalogen 16:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PC(P-16:0/16:1(9Z))

(2-{[(2R)-3-[(1Z)-hexadec-1-en-1-yloxy]-2-[(9Z)-hexadec-9-enoyloxy]propyl phosphonato]oxy}ethyl)trimethylazanium

C40H78NO7P (715.5515607999998)


PC(P-16:0/16:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-16:0/16:1(9Z)), in particular, consists of one chain of plasmalogen 16:0 at the C-1 position and one chain of palmitoleic acid at the C-2 position. The plasmalogen 16:0 moiety is derived from animal fats, liver and kidney, while the palmitoleic acid moiety is derived from animal fats and vegetable oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PC(P-16:0/16:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-16:0/16:1(9Z)), in particular, consists of one chain of plasmalogen 16:0 at the C-1 position and one chain of palmitoleic acid at the C-2 position. The plasmalogen 16:0 moiety is derived from animal fats, liver and kidney, while the palmitoleic acid moiety is derived from animal fats and vegetable oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PC(P-18:0/14:1(9Z))

trimethyl(2-{[(2R)-3-[(1Z)-octadec-1-en-1-yloxy]-2-[(9Z)-tetradec-9-enoyloxy]propyl phosphonato]oxy}ethyl)azanium

C40H78NO7P (715.5515607999998)


PC(P-18:0/14:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:0/14:1(9Z)), in particular, consists of one chain of plasmalogen 18:0 at the C-1 position and one chain of myristoleic acid at the C-2 position. The plasmalogen 18:0 moiety is derived from animal fats, liver and kidney, while the myristoleic acid moiety is derived from milk fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PC(P-18:0/14:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:0/14:1(9Z)), in particular, consists of one chain of plasmalogen 18:0 at the C-1 position and one chain of myristoleic acid at the C-2 position. The plasmalogen 18:0 moiety is derived from animal fats, liver and kidney, while the myristoleic acid moiety is derived from milk fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PC(P-18:1(11Z)/14:0)

trimethyl(2-{[(2R)-3-[(1Z,11Z)-octadeca-1,11-dien-1-yloxy]-2-(tetradecanoyloxy)propyl phosphonato]oxy}ethyl)azanium

C40H78NO7P (715.5515607999998)


PC(P-18:1(11Z)/14:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:1(11Z)/14:0), in particular, consists of one chain of plasmalogen 18:1n7 at the C-1 position and one chain of myristic acid at the C-2 position. The plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney, while the myristic acid moiety is derived from nutmeg and butter. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PC(P-18:1(11Z)/14:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:1(11Z)/14:0), in particular, consists of one chain of plasmalogen 18:1n7 at the C-1 position and one chain of myristic acid at the C-2 position. The plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney, while the myristic acid moiety is derived from nutmeg and butter. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PC(P-18:1(9Z)/14:0)

trimethyl[2-({3-[(1Z,9Z)-octadeca-1,9-dien-1-yloxy]-2-(tetradecanoyloxy)propyl phosphonato}oxy)ethyl]azanium

C40H78NO7P (715.5515607999998)


PC(P-18:1(9Z)/14:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:1(9Z)/14:0), in particular, consists of one chain of plasmalogen 18:1n9 at the C-1 position and one chain of myristic acid at the C-2 position. The plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney, while the myristic acid moiety is derived from nutmeg and butter. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PC(P-18:1(9Z)/14:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:1(9Z)/14:0), in particular, consists of one chain of plasmalogen 18:1n9 at the C-1 position and one chain of myristic acid at the C-2 position. The plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney, while the myristic acid moiety is derived from nutmeg and butter. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PC(O-16:1(9Z)/16:1(9Z))

(2-{[(2R)-3-[(9Z)-hexadec-9-en-1-yloxy]-2-[(9Z)-hexadec-9-enoyloxy]propyl phosphonato]oxy}ethyl)trimethylazanium

C40H78NO7P (715.5515607999998)


PC(O-16:1(9Z)/16:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(O-16:1(9Z)/16:1(9Z)), in particular, consists of one chain of Palmitoleyl alcohol at the C-1 position and one chain of palmitoleic acid at the C-2 position. The Palmitoleyl alcohol moiety is derived from whale oil, while the palmitoleic acid moiety is derived from animal fats and vegetable oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(o-16:1(9Z)/16:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-16:1(9Z)/16:1(9Z)), in particular, consists of one chain of Palmitoleyl alcohol at the C-1 position and one chain of palmitoleic acid at the C-2 position. The Palmitoleyl alcohol moiety is derived from whale oil, while the palmitoleic acid moiety is derived from animal fats and vegetable oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

SM C16:1

{[(2S,3R,11E)-2-[(9E)-hexadec-9-enamido]-3-hydroxynonadec-11-en-1-yl]oxy}[2-(trimethylazaniumyl)ethoxy]phosphinic acid

C40H80N2O6P (715.5753690000001)


Sm c16:1 is classified as a member of the phosphocholines. Phosphocholines are compounds containing a [2-(trimethylazaniumyl)ethoxy]phosphonic acid or derivative. Sm c16:1 is considered to be a practically insoluble (in water) and a moderately acidic compound. Sm c16:1 can be found in blood and urine. Within a cell, Sm c16:1 is primarily located near the membrane (predicted from logp).

   

Carotene-zeta

trimethyl(2-{[(2R)-2-[(9Z,12Z)-octadeca-9,12-dienoyloxy]-3-(tetradecyloxy)propyl phosphono]oxy}ethyl)azanium

C40H78NO7P (715.5515607999998)


   

1-O-(1Z-Tetradecenyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine

1-O-(1Z-Tetradecenyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine

C40H78NO7P (715.5515607999998)


   

(2S,3R,8E)-1-(beta-D-glucopyranosyl-3-hydroxy-2-[(R)-2-hydroxypalmitoyl]amino-8-octadecaene)|(2S,3R,8E,2R)-2-N-(2-hydroxyhexadecanoyl)-1-O-(beta-D-glucopyranosyl)-8-sphingenine|1-O-beta-D-glucopyranosyl-(2S,3R,8E)-2-[(2R)-2-hydroxypalmitoylamino]-8-octadecene-1,3-diol

(2S,3R,8E)-1-(beta-D-glucopyranosyl-3-hydroxy-2-[(R)-2-hydroxypalmitoyl]amino-8-octadecaene)|(2S,3R,8E,2R)-2-N-(2-hydroxyhexadecanoyl)-1-O-(beta-D-glucopyranosyl)-8-sphingenine|1-O-beta-D-glucopyranosyl-(2S,3R,8E)-2-[(2R)-2-hydroxypalmitoylamino]-8-octadecene-1,3-diol

C40H77NO9 (715.5598032)


   

(2S,3S,4R,8Z)-1-O-(beta-D-glucopyranosyl)-2-(palmitoylamino)-8-actadecene-1,3,4-triol|(2S,3S,4R,8Z)-1-O-(beta-D-glucopyranosyl)-2-[(palmitoyl)amino]octadec-8-ene-1,3,4-triol|1-O-beta-D-glucopyranosyl-(2S,3S,4R,8Z)-2-[palmitoylamino]-8-octadecene-1,3,4-triol

(2S,3S,4R,8Z)-1-O-(beta-D-glucopyranosyl)-2-(palmitoylamino)-8-actadecene-1,3,4-triol|(2S,3S,4R,8Z)-1-O-(beta-D-glucopyranosyl)-2-[(palmitoyl)amino]octadec-8-ene-1,3,4-triol|1-O-beta-D-glucopyranosyl-(2S,3S,4R,8Z)-2-[palmitoylamino]-8-octadecene-1,3,4-triol

C40H77NO9 (715.5598032)


   

(2R)-N-{(1S,2R,8E)-1-[(beta-D-glucopyranosyloxy)methyl]-2-hydroxyheptadec-8-en-1-yl}-2-hydroxyhexadecanamide

(2R)-N-{(1S,2R,8E)-1-[(beta-D-glucopyranosyloxy)methyl]-2-hydroxyheptadec-8-en-1-yl}-2-hydroxyhexadecanamide

C40H77NO9 (715.5598032)


   

GlcCer(d14:1(4E)/20:0(2OH))

N-(2-hydroxy-eicosanoyl)-1-beta-glucosyl-tetradecasphing-4-enine

C40H77NO9 (715.5598032)


   

PC(O-14:0/18:2)

3,5,8-Trioxa-4-phosphahexacosa-17,20-dien-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[(tetradecyloxy)methyl]-, inner salt, 4-oxide, [R-(Z,Z)]-

C40H78NO7P (715.5515607999998)


   

PC(P-14:0/18:1)

1-O-(1Z-Tetradecenyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine

C40H78NO7P (715.5515607999998)


   

Lecithin

1-(1-Enyl-palmitoyl)-2-palmitoleoyl-sn-glycero-3-phosphocholine

C40H78NO7P (715.5515607999998)


   

PE(O-18:0/17:2(9Z,12Z))

1-octadecyl-2-(9Z,12Z-heptadecadienoyl)-glycero-3-phosphoethanolamine

C40H78NO7P (715.5515607999998)


   

PE(P-16:0/19:1(9Z))

1-(1Z-hexadecenyl)-2-(9Z-nonadecenoyl)-glycero-3-phosphoethanolamine

C40H78NO7P (715.5515607999998)


   

PE(P-18:0/17:1(9Z))

1-(1Z-octadecenyl)-2-(9Z-heptadecenoyl)-glycero-3-phosphoethanolamine

C40H78NO7P (715.5515607999998)


   

PE(P-20:0/15:1(9Z))

1-(1Z-eicosenyl)-2-(9Z-pentadecenoyl)-glycero-3-phosphoethanolamine

C40H78NO7P (715.5515607999998)


   

SM C16:1

{[(2S,3R,11E)-2-[(9E)-hexadec-9-enamido]-3-hydroxynonadec-11-en-1-yl]oxy}[2-(trimethylazaniumyl)ethoxy]phosphinic acid

C40H80N2O6P (715.5753690000001)


   

AS 1-5

2-hydroxy-N-[(4E)-3-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadec-4-en-2-yl]hexadecanamide

C40H77NO9 (715.5598032)


   

PC O-32:2

1-(1Z,11Z-octadecadienyl)-2-tetradecanoyl-sn-glycero-3-phosphocholine

C40H78NO7P (715.5515607999998)


   

PE O-35:2

1-(1Z-octadecenyl)-2-(9Z-heptadecenoyl)-glycero-3-phosphoethanolamine

C40H78NO7P (715.5515607999998)


   

HexCer 34:1;O3

N-(2R-hydroxyhexadecanoyl)-1-beta-glucosyl-8Z-octadecasphingenine

C40H77NO9 (715.5598032)


   

SM C16:1

{[(2S,3R,11E)-2-[(9E)-hexadec-9-enamido]-3-hydroxynonadec-11-en-1-yl]oxy}[2-(trimethylazaniumyl)ethoxy]phosphinic acid

C40H80N2O6P+ (715.5753690000001)


Sm c16:1 is classified as a member of the phosphocholines. Phosphocholines are compounds containing a [2-(trimethylazaniumyl)ethoxy]phosphonic acid or derivative. Sm c16:1 is considered to be a practically insoluble (in water) and a moderately acidic compound. Sm c16:1 can be found in blood and urine. Within a cell, Sm c16:1 is primarily located near the membrane (predicted from logp).

   

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[8-[3-[(Z)-oct-2-enyl]oxiran-2-yl]octanoylamino]hexadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[8-[3-[(Z)-oct-2-enyl]oxiran-2-yl]octanoylamino]hexadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C39H76N2O7P+ (715.5389855999999)


   

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]amino]hexadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]amino]hexadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C39H76N2O7P+ (715.5389855999999)


   

N-(2-hydroxyheptadecanoyl)-1-O-beta-D-glucosyl-15-methylhexadecasphing-4-enine

N-(2-hydroxyheptadecanoyl)-1-O-beta-D-glucosyl-15-methylhexadecasphing-4-enine

C40H77NO9 (715.5598032)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

HexCer 10:0;2O/25:0

HexCer 10:0;2O/25:0

C41H81NO8 (715.5961866)


   

HexCer 25:0;2O/10:0

HexCer 25:0;2O/10:0

C41H81NO8 (715.5961866)


   

HexCer 24:0;2O/11:0

HexCer 24:0;2O/11:0

C41H81NO8 (715.5961866)


   

HexCer 13:0;2O/22:0

HexCer 13:0;2O/22:0

C41H81NO8 (715.5961866)


   

HexCer 12:0;2O/23:0

HexCer 12:0;2O/23:0

C41H81NO8 (715.5961866)


   

HexCer 11:0;2O/24:0

HexCer 11:0;2O/24:0

C41H81NO8 (715.5961866)


   

(13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(E)-1,3-dihydroxyoct-4-en-2-yl]tetraconta-13,16,19,22,25,28,31,34,37-nonaenamide

(13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(E)-1,3-dihydroxyoct-4-en-2-yl]tetraconta-13,16,19,22,25,28,31,34,37-nonaenamide

C48H77NO3 (715.5903132)


   

HexCer 16:0;2O/18:1;O

HexCer 16:0;2O/18:1;O

C40H77NO9 (715.5598032)


   

HexCer 22:0;2O/12:1;O

HexCer 22:0;2O/12:1;O

C40H77NO9 (715.5598032)


   

HexCer 19:1;2O/15:0;O

HexCer 19:1;2O/15:0;O

C40H77NO9 (715.5598032)


   

HexCer 20:1;2O/14:0;O

HexCer 20:1;2O/14:0;O

C40H77NO9 (715.5598032)


   

HexCer 16:1;2O/18:0;O

HexCer 16:1;2O/18:0;O

C40H77NO9 (715.5598032)


   

HexCer 17:1;2O/17:0;O

HexCer 17:1;2O/17:0;O

C40H77NO9 (715.5598032)


   

HexCer 21:1;2O/13:0;O

HexCer 21:1;2O/13:0;O

C40H77NO9 (715.5598032)


   

HexCer 22:1;2O/12:0;O

HexCer 22:1;2O/12:0;O

C40H77NO9 (715.5598032)


   

HexCer 20:0;2O/14:1;O

HexCer 20:0;2O/14:1;O

C40H77NO9 (715.5598032)


   

HexCer 17:0;2O/17:1;O

HexCer 17:0;2O/17:1;O

C40H77NO9 (715.5598032)


   

HexCer 19:0;2O/15:1;O

HexCer 19:0;2O/15:1;O

C40H77NO9 (715.5598032)


   

HexCer 21:0;2O/13:1;O

HexCer 21:0;2O/13:1;O

C40H77NO9 (715.5598032)


   

HexCer 18:0;2O/16:1;O

HexCer 18:0;2O/16:1;O

C40H77NO9 (715.5598032)


   

[3-octoxy-2-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-octoxy-2-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO7P (715.5515607999998)


   

(5Z,8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-N-[(E)-1,3-dihydroxyhexadec-4-en-2-yl]dotriaconta-5,8,11,14,17,20,23,26,29-nonaenamide

(5Z,8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-N-[(E)-1,3-dihydroxyhexadec-4-en-2-yl]dotriaconta-5,8,11,14,17,20,23,26,29-nonaenamide

C48H77NO3 (715.5903132)


   

(13Z,16Z,19Z,22Z,25Z,28Z,31Z)-N-[(4E,8E,12E)-1,3-dihydroxytetradeca-4,8,12-trien-2-yl]tetratriaconta-13,16,19,22,25,28,31-heptaenamide

(13Z,16Z,19Z,22Z,25Z,28Z,31Z)-N-[(4E,8E,12E)-1,3-dihydroxytetradeca-4,8,12-trien-2-yl]tetratriaconta-13,16,19,22,25,28,31-heptaenamide

C48H77NO3 (715.5903132)


   

(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-N-[(4E,8E,12E)-1,3-dihydroxydocosa-4,8,12-trien-2-yl]hexacosa-5,8,11,14,17,20,23-heptaenamide

(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-N-[(4E,8E,12E)-1,3-dihydroxydocosa-4,8,12-trien-2-yl]hexacosa-5,8,11,14,17,20,23-heptaenamide

C48H77NO3 (715.5903132)


   

(8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-N-[(4E,8E)-1,3-dihydroxyhexadeca-4,8-dien-2-yl]dotriaconta-8,11,14,17,20,23,26,29-octaenamide

(8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-N-[(4E,8E)-1,3-dihydroxyhexadeca-4,8-dien-2-yl]dotriaconta-8,11,14,17,20,23,26,29-octaenamide

C48H77NO3 (715.5903132)


   

(10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-N-[(4E,8E)-1,3-dihydroxytetradeca-4,8-dien-2-yl]tetratriaconta-10,13,16,19,22,25,28,31-octaenamide

(10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-N-[(4E,8E)-1,3-dihydroxytetradeca-4,8-dien-2-yl]tetratriaconta-10,13,16,19,22,25,28,31-octaenamide

C48H77NO3 (715.5903132)


   

(11Z,14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z)-N-[(E)-1,3-dihydroxydec-4-en-2-yl]octatriaconta-11,14,17,20,23,26,29,32,35-nonaenamide

(11Z,14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z)-N-[(E)-1,3-dihydroxydec-4-en-2-yl]octatriaconta-11,14,17,20,23,26,29,32,35-nonaenamide

C48H77NO3 (715.5903132)


   

(9Z,12Z,15Z,18Z,21Z,24Z,27Z)-N-[(4E,8E,12E)-1,3-dihydroxyoctadeca-4,8,12-trien-2-yl]triaconta-9,12,15,18,21,24,27-heptaenamide

(9Z,12Z,15Z,18Z,21Z,24Z,27Z)-N-[(4E,8E,12E)-1,3-dihydroxyoctadeca-4,8,12-trien-2-yl]triaconta-9,12,15,18,21,24,27-heptaenamide

C48H77NO3 (715.5903132)


   

(12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-N-[(4E,8E)-1,3-dihydroxydodeca-4,8-dien-2-yl]hexatriaconta-12,15,18,21,24,27,30,33-octaenamide

(12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-N-[(4E,8E)-1,3-dihydroxydodeca-4,8-dien-2-yl]hexatriaconta-12,15,18,21,24,27,30,33-octaenamide

C48H77NO3 (715.5903132)


   

(11Z,14Z,17Z,20Z,23Z,26Z,29Z)-N-[(4E,8E,12E)-1,3-dihydroxyhexadeca-4,8,12-trien-2-yl]dotriaconta-11,14,17,20,23,26,29-heptaenamide

(11Z,14Z,17Z,20Z,23Z,26Z,29Z)-N-[(4E,8E,12E)-1,3-dihydroxyhexadeca-4,8,12-trien-2-yl]dotriaconta-11,14,17,20,23,26,29-heptaenamide

C48H77NO3 (715.5903132)


   

(7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-N-[(E)-1,3-dihydroxytetradec-4-en-2-yl]tetratriaconta-7,10,13,16,19,22,25,28,31-nonaenamide

(7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-N-[(E)-1,3-dihydroxytetradec-4-en-2-yl]tetratriaconta-7,10,13,16,19,22,25,28,31-nonaenamide

C48H77NO3 (715.5903132)


   

(9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-N-[(E)-1,3-dihydroxydodec-4-en-2-yl]hexatriaconta-9,12,15,18,21,24,27,30,33-nonaenamide

(9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-N-[(E)-1,3-dihydroxydodec-4-en-2-yl]hexatriaconta-9,12,15,18,21,24,27,30,33-nonaenamide

C48H77NO3 (715.5903132)


   

(7Z,10Z,13Z,16Z,19Z,22Z,25Z)-N-[(4E,8E,12E)-1,3-dihydroxyicosa-4,8,12-trien-2-yl]octacosa-7,10,13,16,19,22,25-heptaenamide

(7Z,10Z,13Z,16Z,19Z,22Z,25Z)-N-[(4E,8E,12E)-1,3-dihydroxyicosa-4,8,12-trien-2-yl]octacosa-7,10,13,16,19,22,25-heptaenamide

C48H77NO3 (715.5903132)


   

(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z)-N-[(4E,8E)-1,3-dihydroxyoctadeca-4,8-dien-2-yl]triaconta-6,9,12,15,18,21,24,27-octaenamide

(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z)-N-[(4E,8E)-1,3-dihydroxyoctadeca-4,8-dien-2-yl]triaconta-6,9,12,15,18,21,24,27-octaenamide

C48H77NO3 (715.5903132)


   

(10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-(1,3-dihydroxyoctan-2-yl)tetraconta-10,13,16,19,22,25,28,31,34,37-decaenamide

(10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-(1,3-dihydroxyoctan-2-yl)tetraconta-10,13,16,19,22,25,28,31,34,37-decaenamide

C48H77NO3 (715.5903132)


   

(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-N-(1,3-dihydroxydodecan-2-yl)hexatriaconta-6,9,12,15,18,21,24,27,30,33-decaenamide

(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-N-(1,3-dihydroxydodecan-2-yl)hexatriaconta-6,9,12,15,18,21,24,27,30,33-decaenamide

C48H77NO3 (715.5903132)


   

(8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z)-N-(1,3-dihydroxydecan-2-yl)octatriaconta-8,11,14,17,20,23,26,29,32,35-decaenamide

(8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z)-N-(1,3-dihydroxydecan-2-yl)octatriaconta-8,11,14,17,20,23,26,29,32,35-decaenamide

C48H77NO3 (715.5903132)


   

(E)-3-hydroxy-2-(2-hydroxyhexadecanoylamino)pentacos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(2-hydroxyhexadecanoylamino)pentacos-4-ene-1-sulfonic acid

C41H81NO6S (715.5784286)


   

(E)-3-hydroxy-2-(2-hydroxynonadecanoylamino)docos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(2-hydroxynonadecanoylamino)docos-4-ene-1-sulfonic acid

C41H81NO6S (715.5784286)


   

3-hydroxy-2-[[(Z)-2-hydroxyicos-11-enoyl]amino]henicosane-1-sulfonic acid

3-hydroxy-2-[[(Z)-2-hydroxyicos-11-enoyl]amino]henicosane-1-sulfonic acid

C41H81NO6S (715.5784286)


   

3-hydroxy-2-[[(Z)-2-hydroxynonadec-9-enoyl]amino]docosane-1-sulfonic acid

3-hydroxy-2-[[(Z)-2-hydroxynonadec-9-enoyl]amino]docosane-1-sulfonic acid

C41H81NO6S (715.5784286)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(17Z,20Z)-octacosa-17,20-dienoxy]propan-2-yl] heptanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(17Z,20Z)-octacosa-17,20-dienoxy]propan-2-yl] heptanoate

C40H78NO7P (715.5515607999998)


   

(E)-3-hydroxy-2-(2-hydroxyhexacosanoylamino)pentadec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(2-hydroxyhexacosanoylamino)pentadec-4-ene-1-sulfonic acid

C41H81NO6S (715.5784286)


   

3-hydroxy-2-[[(Z)-2-hydroxyhexacos-11-enoyl]amino]pentadecane-1-sulfonic acid

3-hydroxy-2-[[(Z)-2-hydroxyhexacos-11-enoyl]amino]pentadecane-1-sulfonic acid

C41H81NO6S (715.5784286)


   

3-hydroxy-2-[[(Z)-2-hydroxypentadec-9-enoyl]amino]hexacosane-1-sulfonic acid

3-hydroxy-2-[[(Z)-2-hydroxypentadec-9-enoyl]amino]hexacosane-1-sulfonic acid

C41H81NO6S (715.5784286)


   

(E)-3-hydroxy-2-(2-hydroxyoctadecanoylamino)tricos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(2-hydroxyoctadecanoylamino)tricos-4-ene-1-sulfonic acid

C41H81NO6S (715.5784286)


   

(E)-3-hydroxy-2-(2-hydroxyheptadecanoylamino)tetracos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(2-hydroxyheptadecanoylamino)tetracos-4-ene-1-sulfonic acid

C41H81NO6S (715.5784286)


   

(E)-3-hydroxy-2-(2-hydroxydocosanoylamino)nonadec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(2-hydroxydocosanoylamino)nonadec-4-ene-1-sulfonic acid

C41H81NO6S (715.5784286)


   

3-hydroxy-2-[[(Z)-2-hydroxyhenicos-9-enoyl]amino]icosane-1-sulfonic acid

3-hydroxy-2-[[(Z)-2-hydroxyhenicos-9-enoyl]amino]icosane-1-sulfonic acid

C41H81NO6S (715.5784286)


   

3-hydroxy-2-[[(Z)-2-hydroxytetracos-11-enoyl]amino]heptadecane-1-sulfonic acid

3-hydroxy-2-[[(Z)-2-hydroxytetracos-11-enoyl]amino]heptadecane-1-sulfonic acid

C41H81NO6S (715.5784286)


   

(E)-3-hydroxy-2-(2-hydroxyhenicosanoylamino)icos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(2-hydroxyhenicosanoylamino)icos-4-ene-1-sulfonic acid

C41H81NO6S (715.5784286)


   

(E)-3-hydroxy-2-(2-hydroxypentadecanoylamino)hexacos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(2-hydroxypentadecanoylamino)hexacos-4-ene-1-sulfonic acid

C41H81NO6S (715.5784286)


   

(E)-3-hydroxy-2-(2-hydroxytricosanoylamino)octadec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(2-hydroxytricosanoylamino)octadec-4-ene-1-sulfonic acid

C41H81NO6S (715.5784286)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonoxypropan-2-yl] (15Z,18Z)-hexacosa-15,18-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonoxypropan-2-yl] (15Z,18Z)-hexacosa-15,18-dienoate

C40H78NO7P (715.5515607999998)


   

(E)-3-hydroxy-2-(2-hydroxypentacosanoylamino)hexadec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(2-hydroxypentacosanoylamino)hexadec-4-ene-1-sulfonic acid

C41H81NO6S (715.5784286)


   

3-hydroxy-2-[[(Z)-2-hydroxytricos-11-enoyl]amino]octadecane-1-sulfonic acid

3-hydroxy-2-[[(Z)-2-hydroxytricos-11-enoyl]amino]octadecane-1-sulfonic acid

C41H81NO6S (715.5784286)


   

3-hydroxy-2-[[(Z)-2-hydroxyoctadec-11-enoyl]amino]tricosane-1-sulfonic acid

3-hydroxy-2-[[(Z)-2-hydroxyoctadec-11-enoyl]amino]tricosane-1-sulfonic acid

C41H81NO6S (715.5784286)


   

(E)-3-hydroxy-2-(2-hydroxyicosanoylamino)henicos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(2-hydroxyicosanoylamino)henicos-4-ene-1-sulfonic acid

C41H81NO6S (715.5784286)


   

(E)-3-hydroxy-2-(2-hydroxytetracosanoylamino)heptadec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(2-hydroxytetracosanoylamino)heptadec-4-ene-1-sulfonic acid

C41H81NO6S (715.5784286)


   

3-hydroxy-2-[[(Z)-2-hydroxypentacos-11-enoyl]amino]hexadecane-1-sulfonic acid

3-hydroxy-2-[[(Z)-2-hydroxypentacos-11-enoyl]amino]hexadecane-1-sulfonic acid

C41H81NO6S (715.5784286)


   

3-hydroxy-2-[[(Z)-2-hydroxyhexadec-7-enoyl]amino]pentacosane-1-sulfonic acid

3-hydroxy-2-[[(Z)-2-hydroxyhexadec-7-enoyl]amino]pentacosane-1-sulfonic acid

C41H81NO6S (715.5784286)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(15Z,18Z)-hexacosa-15,18-dienoxy]propan-2-yl] nonanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(15Z,18Z)-hexacosa-15,18-dienoxy]propan-2-yl] nonanoate

C40H78NO7P (715.5515607999998)


   

3-hydroxy-2-[[(Z)-2-hydroxydocos-11-enoyl]amino]nonadecane-1-sulfonic acid

3-hydroxy-2-[[(Z)-2-hydroxydocos-11-enoyl]amino]nonadecane-1-sulfonic acid

C41H81NO6S (715.5784286)


   

[2-octanoyloxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-octanoyloxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO7P (715.5515607999998)


   

[2-butanoyloxy-3-[(17Z,20Z)-octacosa-17,20-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-butanoyloxy-3-[(17Z,20Z)-octacosa-17,20-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO7P (715.5515607999998)


   

[3-[(15Z,18Z)-hexacosa-15,18-dienoxy]-2-hexanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(15Z,18Z)-hexacosa-15,18-dienoxy]-2-hexanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO7P (715.5515607999998)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propan-2-yl] pentadecanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propan-2-yl] pentadecanoate

C40H78NO7P (715.5515607999998)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecoxypropan-2-yl] (13Z,16Z)-tetracosa-13,16-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecoxypropan-2-yl] (13Z,16Z)-tetracosa-13,16-dienoate

C40H78NO7P (715.5515607999998)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecoxypropan-2-yl] (13Z,16Z)-docosa-13,16-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecoxypropan-2-yl] (13Z,16Z)-docosa-13,16-dienoate

C40H78NO7P (715.5515607999998)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z)-henicosa-11,14-dienoxy]propan-2-yl] tetradecanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z)-henicosa-11,14-dienoxy]propan-2-yl] tetradecanoate

C40H78NO7P (715.5515607999998)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(13Z,16Z)-docosa-13,16-dienoxy]propan-2-yl] tridecanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(13Z,16Z)-docosa-13,16-dienoxy]propan-2-yl] tridecanoate

C40H78NO7P (715.5515607999998)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propan-2-yl] undecanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propan-2-yl] undecanoate

C40H78NO7P (715.5515607999998)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-henicos-11-enoxy]propan-2-yl] (Z)-tetradec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-henicos-11-enoxy]propan-2-yl] (Z)-tetradec-9-enoate

C40H78NO7P (715.5515607999998)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonadecoxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonadecoxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

C40H78NO7P (715.5515607999998)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-heptadeca-9,12-dienoxy]propan-2-yl] octadecanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-heptadeca-9,12-dienoxy]propan-2-yl] octadecanoate

C40H78NO7P (715.5515607999998)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecoxypropan-2-yl] (11Z,14Z)-icosa-11,14-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecoxypropan-2-yl] (11Z,14Z)-icosa-11,14-dienoate

C40H78NO7P (715.5515607999998)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-docos-13-enoxy]propan-2-yl] (Z)-tridec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-docos-13-enoxy]propan-2-yl] (Z)-tridec-9-enoate

C40H78NO7P (715.5515607999998)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-icos-11-enoxy]propan-2-yl] (Z)-pentadec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-icos-11-enoxy]propan-2-yl] (Z)-pentadec-9-enoate

C40H78NO7P (715.5515607999998)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] (Z)-icos-11-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] (Z)-icos-11-enoate

C40H78NO7P (715.5515607999998)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] (Z)-docos-13-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] (Z)-docos-13-enoate

C40H78NO7P (715.5515607999998)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-heptadec-9-enoxy]propan-2-yl] (Z)-octadec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-heptadec-9-enoxy]propan-2-yl] (Z)-octadec-9-enoate

C40H78NO7P (715.5515607999998)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-nonadec-9-enoxy]propan-2-yl] (Z)-hexadec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-nonadec-9-enoxy]propan-2-yl] (Z)-hexadec-9-enoate

C40H78NO7P (715.5515607999998)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecoxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecoxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

C40H78NO7P (715.5515607999998)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propan-2-yl] hexadecanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propan-2-yl] hexadecanoate

C40H78NO7P (715.5515607999998)


   

[2-dodecanoyloxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-dodecanoyloxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO7P (715.5515607999998)


   

[3-[(Z)-heptadec-9-enoxy]-2-[(Z)-pentadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(Z)-heptadec-9-enoxy]-2-[(Z)-pentadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO7P (715.5515607999998)


   

[2-[(Z)-nonadec-9-enoyl]oxy-3-[(Z)-tridec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(Z)-nonadec-9-enoyl]oxy-3-[(Z)-tridec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO7P (715.5515607999998)


   

[3-[(11Z,14Z)-henicosa-11,14-dienoxy]-2-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(11Z,14Z)-henicosa-11,14-dienoxy]-2-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO7P (715.5515607999998)


   

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-pentadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-pentadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO7P (715.5515607999998)


   

[3-[(9Z,12Z)-heptadeca-9,12-dienoxy]-2-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(9Z,12Z)-heptadeca-9,12-dienoxy]-2-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO7P (715.5515607999998)


   

[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-tridecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-tridecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO7P (715.5515607999998)


   

[2-decanoyloxy-3-[(13Z,16Z)-docosa-13,16-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-decanoyloxy-3-[(13Z,16Z)-docosa-13,16-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO7P (715.5515607999998)


   

[3-decoxy-2-[(13Z,16Z)-docosa-13,16-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-decoxy-2-[(13Z,16Z)-docosa-13,16-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO7P (715.5515607999998)


   

[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-undecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-undecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO7P (715.5515607999998)


   

[2-[(Z)-heptadec-9-enoyl]oxy-3-[(Z)-pentadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(Z)-heptadec-9-enoyl]oxy-3-[(Z)-pentadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO7P (715.5515607999998)


   

[3-[(Z)-nonadec-9-enoxy]-2-[(Z)-tridec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(Z)-nonadec-9-enoxy]-2-[(Z)-tridec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO7P (715.5515607999998)


   

[3-dodecoxy-2-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-dodecoxy-2-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO7P (715.5515607999998)


   

[3-[(9Z,12Z)-nonadeca-9,12-dienoxy]-2-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(9Z,12Z)-nonadeca-9,12-dienoxy]-2-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO7P (715.5515607999998)


   

2-[4-(12-hydroxy-10,13-dimethyl-3-octadecanoyloxy-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoylamino]acetic acid

2-[4-(12-hydroxy-10,13-dimethyl-3-octadecanoyloxy-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoylamino]acetic acid

C44H77NO6 (715.5750582000001)


   
   

HexCer 14:0;2O/21:0

HexCer 14:0;2O/21:0

C41H81NO8 (715.5961866)


   

HexCer 15:0;2O/20:0

HexCer 15:0;2O/20:0

C41H81NO8 (715.5961866)


   

HexCer 16:0;2O/19:0

HexCer 16:0;2O/19:0

C41H81NO8 (715.5961866)


   

HexCer 17:0;2O/18:0

HexCer 17:0;2O/18:0

C41H81NO8 (715.5961866)


   

HexCer 18:0;2O/17:0

HexCer 18:0;2O/17:0

C41H81NO8 (715.5961866)


   

HexCer 19:0;2O/16:0

HexCer 19:0;2O/16:0

C41H81NO8 (715.5961866)


   

HexCer 20:0;2O/15:0

HexCer 20:0;2O/15:0

C41H81NO8 (715.5961866)


   

HexCer 21:0;2O/14:0

HexCer 21:0;2O/14:0

C41H81NO8 (715.5961866)


   

HexCer 22:0;2O/13:0

HexCer 22:0;2O/13:0

C41H81NO8 (715.5961866)


   

HexCer 23:0;2O/12:0

HexCer 23:0;2O/12:0

C41H81NO8 (715.5961866)


   

N-(tetracosanoyl)-4E-heptadecasphingenine-1-phosphate

N-(tetracosanoyl)-4E-heptadecasphingenine-1-phosphate

C41H82NO6P (715.5879442)


   

N-(docosanoyl)-4E-nonadecasphingenine-1-phosphate

N-(docosanoyl)-4E-nonadecasphingenine-1-phosphate

C41H82NO6P (715.5879442)


   

N-(hexacosanoyl)-4E-pentadecasphingenine-1-phosphate

N-(hexacosanoyl)-4E-pentadecasphingenine-1-phosphate

C41H82NO6P (715.5879442)


   
   
   

[3-[(Z)-octadec-9-enoxy]-2-[(Z)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(Z)-octadec-9-enoxy]-2-[(Z)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO7P (715.5515607999998)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecoxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecoxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate

C40H78NO7P (715.5515607999998)


   

[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-tetradecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-tetradecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO7P (715.5515607999998)


   

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-hexadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-hexadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO7P (715.5515607999998)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecoxypropan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecoxypropan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate

C40H78NO7P (715.5515607999998)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-octadec-9-enoxy]propan-2-yl] (Z)-heptadec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-octadec-9-enoxy]propan-2-yl] (Z)-heptadec-9-enoate

C40H78NO7P (715.5515607999998)


   

[2-[(Z)-octadec-9-enoyl]oxy-3-[(Z)-tetradec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(Z)-octadec-9-enoyl]oxy-3-[(Z)-tetradec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO7P (715.5515607999998)


   

[3-[(Z)-hexadec-9-enoxy]-2-[(Z)-hexadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(Z)-hexadec-9-enoxy]-2-[(Z)-hexadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO7P (715.5515607999998)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-hexadeca-9,12-dienoxy]propan-2-yl] nonadecanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-hexadeca-9,12-dienoxy]propan-2-yl] nonadecanoate

C40H78NO7P (715.5515607999998)


   

[3-[(9Z,12Z)-hexadeca-9,12-dienoxy]-2-hexadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(9Z,12Z)-hexadeca-9,12-dienoxy]-2-hexadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO7P (715.5515607999998)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-hexadec-9-enoxy]propan-2-yl] (Z)-nonadec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-hexadec-9-enoxy]propan-2-yl] (Z)-nonadec-9-enoate

C40H78NO7P (715.5515607999998)


   

[3-[(9Z,12Z)-octadeca-9,12-dienoxy]-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(9Z,12Z)-octadeca-9,12-dienoxy]-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO7P (715.5515607999998)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octadecoxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octadecoxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

C40H78NO7P (715.5515607999998)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propan-2-yl] heptadecanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propan-2-yl] heptadecanoate

C40H78NO7P (715.5515607999998)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] (Z)-henicos-11-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] (Z)-henicos-11-enoate

C40H78NO7P (715.5515607999998)


   

N-(pentadecanoyl)-1-beta-glucosyl-eicosasphinganine

N-(pentadecanoyl)-1-beta-glucosyl-eicosasphinganine

C41H81NO8 (715.5961866)


   

N-(hexadecanoyl)-1-beta-glucosyl-nonadecasphinganine

N-(hexadecanoyl)-1-beta-glucosyl-nonadecasphinganine

C41H81NO8 (715.5961866)


   

N-(tetradecanoyl)-1-beta-glucosyl-heneicosasphinganine

N-(tetradecanoyl)-1-beta-glucosyl-heneicosasphinganine

C41H81NO8 (715.5961866)


   

N-(tridecanoyl)-1-beta-glucosyl-docosasphinganine

N-(tridecanoyl)-1-beta-glucosyl-docosasphinganine

C41H81NO8 (715.5961866)


   

2-[[(2S,3R,4E,8E)-2-(heptadecanoylamino)-3-hydroxyoctadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2S,3R,4E,8E)-2-(heptadecanoylamino)-3-hydroxyoctadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[hydroxy-[(2S,3R,4E,6E)-3-hydroxy-2-(nonadecanoylamino)hexadeca-4,6-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R,4E,6E)-3-hydroxy-2-(nonadecanoylamino)hexadeca-4,6-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[hydroxy-[(2S,3R,4E,8E)-3-hydroxy-2-(icosanoylamino)pentadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R,4E,8E)-3-hydroxy-2-(icosanoylamino)pentadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

[(2S,3R)-2-[[(E)-hexacos-17-enoyl]amino]-3-hydroxypentadecyl] dihydrogen phosphate

[(2S,3R)-2-[[(E)-hexacos-17-enoyl]amino]-3-hydroxypentadecyl] dihydrogen phosphate

C41H82NO6P (715.5879442)


   

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(E)-icos-11-enoyl]amino]pentadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(E)-icos-11-enoyl]amino]pentadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[hydroxy-[(2S,3R,4E,8E)-3-hydroxy-2-(pentadecanoylamino)icosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R,4E,8E)-3-hydroxy-2-(pentadecanoylamino)icosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[hydroxy-[(2S,3R,4E,8E)-3-hydroxy-2-(octadecanoylamino)heptadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R,4E,8E)-3-hydroxy-2-(octadecanoylamino)heptadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[hydroxy-[(2R,3S,4E,8E)-3-hydroxy-2-(tridecanoylamino)docosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2R,3S,4E,8E)-3-hydroxy-2-(tridecanoylamino)docosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(E)-octadec-9-enoyl]amino]heptadec-8-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(E)-octadec-9-enoyl]amino]heptadec-8-enoxy]phosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(E)-octadec-9-enoyl]amino]heptadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(E)-octadec-9-enoyl]amino]heptadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

[(2R)-3-[(E)-hexadec-1-enoxy]-2-[(E)-hexadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-[(E)-hexadec-1-enoxy]-2-[(E)-hexadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO7P (715.5515607999998)


   

N-[(2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradecan-2-yl]henicosanamide

N-[(2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradecan-2-yl]henicosanamide

C41H81NO8 (715.5961866)


   

[(2R)-3-[(E)-hexadec-1-enoxy]-2-[(E)-hexadec-7-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-[(E)-hexadec-1-enoxy]-2-[(E)-hexadec-7-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO7P (715.5515607999998)


   

2-[hydroxy-[(2S,3R,4E,8E)-3-hydroxy-2-(nonadecanoylamino)hexadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R,4E,8E)-3-hydroxy-2-(nonadecanoylamino)hexadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[[(2S,3R,4E,14E)-2-(heptadecanoylamino)-3-hydroxyoctadeca-4,14-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2S,3R,4E,14E)-2-(heptadecanoylamino)-3-hydroxyoctadeca-4,14-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[[(E,2S,3R)-2-[[(E)-hexadec-9-enoyl]amino]-3-hydroxynonadec-8-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E,2S,3R)-2-[[(E)-hexadec-9-enoyl]amino]-3-hydroxynonadec-8-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[[(E,2S,3R)-2-[[(E)-heptadec-9-enoyl]amino]-3-hydroxyoctadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E,2S,3R)-2-[[(E)-heptadec-9-enoyl]amino]-3-hydroxyoctadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(E)-icos-11-enoyl]amino]pentadec-8-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(E)-icos-11-enoyl]amino]pentadec-8-enoxy]phosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[[(2S,3R,4E,8E)-2-(hexadecanoylamino)-3-hydroxynonadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2S,3R,4E,8E)-2-(hexadecanoylamino)-3-hydroxynonadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

N-[(2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadecan-2-yl]heptadecanamide

N-[(2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadecan-2-yl]heptadecanamide

C41H81NO8 (715.5961866)


   

2-[[(E,2S,3R)-2-[[(E)-hexadec-9-enoyl]amino]-3-hydroxynonadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E,2S,3R)-2-[[(E)-hexadec-9-enoyl]amino]-3-hydroxynonadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

N-[(2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexadecan-2-yl]nonadecanamide

N-[(2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexadecan-2-yl]nonadecanamide

C41H81NO8 (715.5961866)


   

2-[[(2S,3R,4E,8E)-2-(henicosanoylamino)-3-hydroxytetradeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2S,3R,4E,8E)-2-(henicosanoylamino)-3-hydroxytetradeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

N-[(2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptadecan-2-yl]octadecanamide

N-[(2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptadecan-2-yl]octadecanamide

C41H81NO8 (715.5961866)


   

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(9E,12E)-octadeca-9,12-dienoyl]amino]heptadecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(9E,12E)-octadeca-9,12-dienoyl]amino]heptadecoxy]phosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[hydroxy-[(2S,3R,4E,8E)-3-hydroxy-2-(tetradecanoylamino)henicosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R,4E,8E)-3-hydroxy-2-(tetradecanoylamino)henicosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[[(E,2S,3R)-2-[[(E)-heptadec-9-enoyl]amino]-3-hydroxyoctadec-8-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E,2S,3R)-2-[[(E)-heptadec-9-enoyl]amino]-3-hydroxyoctadec-8-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[[(2S,3R,4E,6E)-2-(henicosanoylamino)-3-hydroxytetradeca-4,6-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2S,3R,4E,6E)-2-(henicosanoylamino)-3-hydroxytetradeca-4,6-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

[(2S,3R)-3-hydroxy-2-[[(E)-tetracos-15-enoyl]amino]heptadecyl] dihydrogen phosphate

[(2S,3R)-3-hydroxy-2-[[(E)-tetracos-15-enoyl]amino]heptadecyl] dihydrogen phosphate

C41H82NO6P (715.5879442)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-1-enoxy]propan-2-yl] (E)-heptadec-9-enoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-1-enoxy]propan-2-yl] (E)-heptadec-9-enoate

C40H78NO7P (715.5515607999998)


   

N-[(2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentadecan-2-yl]icosanamide

N-[(2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentadecan-2-yl]icosanamide

C41H81NO8 (715.5961866)


   

2-[hydroxy-[(2S,3R,4E,6E)-3-hydroxy-2-(icosanoylamino)pentadeca-4,6-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R,4E,6E)-3-hydroxy-2-(icosanoylamino)pentadeca-4,6-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

[(2R)-3-[(E)-octadec-1-enoxy]-2-[(E)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-[(E)-octadec-1-enoxy]-2-[(E)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO7P (715.5515607999998)


   

[(2S)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-icos-1-enoxy]propan-2-yl] (E)-pentadec-9-enoate

[(2S)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-icos-1-enoxy]propan-2-yl] (E)-pentadec-9-enoate

C40H78NO7P (715.5515607999998)


   

2-[[(4E,8E)-2-(heptadecanoylamino)-3-hydroxyoctadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-(heptadecanoylamino)-3-hydroxyoctadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(icosanoylamino)pentadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(icosanoylamino)pentadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-icos-11-enoyl]amino]pentadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-icos-11-enoyl]amino]pentadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(pentadecanoylamino)icosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(pentadecanoylamino)icosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(octadecanoylamino)heptadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(octadecanoylamino)heptadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(tridecanoylamino)docosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(tridecanoylamino)docosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(nonadecanoylamino)hexadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(nonadecanoylamino)hexadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[[(E)-2-[[(Z)-dodec-5-enoyl]amino]-3-hydroxytricos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-[[(Z)-dodec-5-enoyl]amino]-3-hydroxytricos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[[(E)-2-[[(Z)-henicos-9-enoyl]amino]-3-hydroxytetradec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-[[(Z)-henicos-9-enoyl]amino]-3-hydroxytetradec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-nonadec-9-enoyl]amino]hexadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-nonadec-9-enoyl]amino]hexadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[[(4E,8E)-2-(hexadecanoylamino)-3-hydroxynonadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-(hexadecanoylamino)-3-hydroxynonadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[[2-[[(4Z,7Z)-hexadeca-4,7-dienoyl]amino]-3-hydroxynonadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-[[(4Z,7Z)-hexadeca-4,7-dienoyl]amino]-3-hydroxynonadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[hydroxy-[3-hydroxy-2-[[(10Z,12Z)-octadeca-10,12-dienoyl]amino]heptadecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-hydroxy-2-[[(10Z,12Z)-octadeca-10,12-dienoyl]amino]heptadecoxy]phosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[hydroxy-[3-hydroxy-2-[[(11Z,14Z)-icosa-11,14-dienoyl]amino]pentadecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-hydroxy-2-[[(11Z,14Z)-icosa-11,14-dienoyl]amino]pentadecoxy]phosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-tridec-8-enoyl]amino]docos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-tridec-8-enoyl]amino]docos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-octadec-11-enoyl]amino]heptadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-octadec-11-enoyl]amino]heptadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[[(4E,8E)-2-(henicosanoylamino)-3-hydroxytetradeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-(henicosanoylamino)-3-hydroxytetradeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(tetradecanoylamino)henicosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(tetradecanoylamino)henicosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[[(E)-2-[[(Z)-hexadec-7-enoyl]amino]-3-hydroxynonadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-[[(Z)-hexadec-7-enoyl]amino]-3-hydroxynonadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]icos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]icos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[[(4E,8E)-2-(dodecanoylamino)-3-hydroxytricosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-(dodecanoylamino)-3-hydroxytricosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]henicos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]henicos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[[2-[[(15Z,18Z)-hexacosa-15,18-dienoyl]amino]-3-hydroxynonoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-[[(15Z,18Z)-hexacosa-15,18-dienoyl]amino]-3-hydroxynonoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[[(4E,8E)-2-(docosanoylamino)-3-hydroxytrideca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-(docosanoylamino)-3-hydroxytrideca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[hydroxy-[3-hydroxy-2-[[(9Z,12Z)-nonadeca-9,12-dienoyl]amino]hexadecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-hydroxy-2-[[(9Z,12Z)-nonadeca-9,12-dienoyl]amino]hexadecoxy]phosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[[(4E,8E)-2-(hexanoylamino)-3-hydroxynonacosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-(hexanoylamino)-3-hydroxynonacosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(nonanoylamino)hexacosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(nonanoylamino)hexacosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(octanoylamino)heptacosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(octanoylamino)heptacosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[[(E)-2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3,4-dihydroxyoctadec-8-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3,4-dihydroxyoctadec-8-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C39H76N2O7P+ (715.5389855999999)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]heptadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]heptadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[[2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxynonadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxynonadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]docos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]docos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[[(E)-2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxyoctadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxyoctadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(undecanoylamino)tetracosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(undecanoylamino)tetracosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[[2-[[(13Z,16Z)-docosa-13,16-dienoyl]amino]-3-hydroxytridecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-[[(13Z,16Z)-docosa-13,16-dienoyl]amino]-3-hydroxytridecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(tricosanoylamino)dodeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(tricosanoylamino)dodeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[[(4E,8E)-2-(butanoylamino)-3-hydroxyhentriaconta-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-(butanoylamino)-3-hydroxyhentriaconta-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(pentanoylamino)triaconta-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(pentanoylamino)triaconta-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[[(E)-2-[[(Z)-docos-13-enoyl]amino]-3-hydroxytridec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-[[(Z)-docos-13-enoyl]amino]-3-hydroxytridec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[[(4E,8E)-2-acetamido-3-hydroxytritriaconta-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-acetamido-3-hydroxytritriaconta-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[[(E)-2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxynonadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxynonadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[[(8E,12E,16E)-2-(hexadecanoylamino)-3,4-dihydroxyoctadeca-8,12,16-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(8E,12E,16E)-2-(hexadecanoylamino)-3,4-dihydroxyoctadeca-8,12,16-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C39H76N2O7P+ (715.5389855999999)


   

2-[[(E)-2-[[(Z)-henicos-11-enoyl]amino]-3-hydroxytetradec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-[[(Z)-henicos-11-enoyl]amino]-3-hydroxytetradec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[hydroxy-[3-hydroxy-2-[[(9Z,12Z)-octadeca-9,12-dienoyl]amino]heptadecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-hydroxy-2-[[(9Z,12Z)-octadeca-9,12-dienoyl]amino]heptadecoxy]phosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[[2-[[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]amino]-3,4-dihydroxyoctadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-[[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]amino]-3,4-dihydroxyoctadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C39H76N2O7P+ (715.5389855999999)


   

2-[[(4E,8E)-2-(decanoylamino)-3-hydroxypentacosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-(decanoylamino)-3-hydroxypentacosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[[(8E,12E)-2-[[(Z)-hexadec-9-enoyl]amino]-3,4-dihydroxyoctadeca-8,12-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(8E,12E)-2-[[(Z)-hexadec-9-enoyl]amino]-3,4-dihydroxyoctadeca-8,12-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C39H76N2O7P+ (715.5389855999999)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(propanoylamino)dotriaconta-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(propanoylamino)dotriaconta-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[[(4E,8E)-2-(heptanoylamino)-3-hydroxyoctacosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-(heptanoylamino)-3-hydroxyoctacosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[[2-[[(9Z,12Z)-heptadeca-9,12-dienoyl]amino]-3-hydroxyoctadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-[[(9Z,12Z)-heptadeca-9,12-dienoyl]amino]-3-hydroxyoctadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-tetracos-13-enoyl]amino]undec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-tetracos-13-enoyl]amino]undec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[[2-[[(11Z,14Z)-henicosa-11,14-dienoyl]amino]-3-hydroxytetradecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-[[(11Z,14Z)-henicosa-11,14-dienoyl]amino]-3-hydroxytetradecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[[(E)-2-[[(Z)-hexacos-15-enoyl]amino]-3-hydroxynon-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-[[(Z)-hexacos-15-enoyl]amino]-3-hydroxynon-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

2-[hydroxy-[3-hydroxy-2-[[(13Z,16Z)-tetracosa-13,16-dienoyl]amino]undecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-hydroxy-2-[[(13Z,16Z)-tetracosa-13,16-dienoyl]amino]undecoxy]phosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

1-(1Z-octadecenyl)-2-(9Z-tetradecenoyl)-glycero-3-phosphocholine

1-(1Z-octadecenyl)-2-(9Z-tetradecenoyl)-glycero-3-phosphocholine

C40H78NO7P (715.5515607999998)


   

1-(1Z,11Z-octadecadienyl)-2-tetradecanoyl-sn-glycero-3-phosphocholine

1-(1Z,11Z-octadecadienyl)-2-tetradecanoyl-sn-glycero-3-phosphocholine

C40H78NO7P (715.5515607999998)


   

1-(1-Enyl-palmitoyl)-2-palmitoleoyl-sn-glycero-3-phosphocholine

1-(1-Enyl-palmitoyl)-2-palmitoleoyl-sn-glycero-3-phosphocholine

C40H78NO7P (715.5515607999998)


   

2-[[(E,2S,3R)-2-[[(E)-hexadec-9-enoyl]amino]-3-hydroxynonadec-11-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E,2S,3R)-2-[[(E)-hexadec-9-enoyl]amino]-3-hydroxynonadec-11-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C40H80N2O6P+ (715.5753690000001)


   

1-Myristoyl-2-(1-enyl-oleoyl)-sn-glycero-3-phosphocholine

1-Myristoyl-2-(1-enyl-oleoyl)-sn-glycero-3-phosphocholine

C40H78NO7P (715.5515607999998)


   

1-myristoleoyl-2-(1-enyl-stearoyl)-sn-glycero-3-phosphocholine

1-myristoleoyl-2-(1-enyl-stearoyl)-sn-glycero-3-phosphocholine

C40H78NO7P (715.5515607999998)


   

1-palmitoleoyl-2-(1-enyl-palmitoyl)-sn-glycero-3-phosphocholine

1-palmitoleoyl-2-(1-enyl-palmitoyl)-sn-glycero-3-phosphocholine

C40H78NO7P (715.5515607999998)


   

1-(1-Enyl-oleoyl)-2-myristoyl-sn-glycero-3-phosphocholine

1-(1-Enyl-oleoyl)-2-myristoyl-sn-glycero-3-phosphocholine

C40H78NO7P (715.5515607999998)


   

1-Myristoyl-2-(1-enyl-vaccenoyl)-sn-glycero-3-phosphocholine

1-Myristoyl-2-(1-enyl-vaccenoyl)-sn-glycero-3-phosphocholine

C40H78NO7P (715.5515607999998)


   

HexCer 18:1;2O/16:0;O

HexCer 18:1;2O/16:0;O

C40H77NO9 (715.5598032)


   
   

GlcCer(d18:1(8Z)/16:0(2OH[R]))

GlcCer(d18:1(8Z)/16:0(2OH[R]))

C40H77NO9 (715.5598032)


   

phosphatidylcholine (P-16:0/16:1)

phosphatidylcholine (P-16:0/16:1)

C40H78NO7P (715.5515607999998)


A phosphatidylcholine P-32:1 in which the 1-alk-1-enyl group contains 16 carbons and no additional double bonds while the 2-acyl group contains 16 carbons and 1 double bond.

   

phosphatidylcholine O-32:2

phosphatidylcholine O-32:2

C40H78NO7P (715.5515607999998)


An alkyl,acyl-sn-glycero-3-phosphocholine in which the alkyl or acyl groups at positions 1 and 2 contain a total of 32 carbons and 2 double bonds.

   

1-[(9Z)-hexadecenyl]-2-[(9Z)-hexadecenoyl]-sn-glycero-3-phosphocholine

1-[(9Z)-hexadecenyl]-2-[(9Z)-hexadecenoyl]-sn-glycero-3-phosphocholine

C40H78NO7P (715.5515607999998)


A phosphatidylcholine O-32:2 in which the alkyl and acyl groups specified at positions 1 and 2 are (9Z)-hexadecenyl and (9Z)-hexadecenoyl respectively.

   

1-(1Z-hexadecenyl)-2-(9Z-hexadecenoyl)-sn-glycero-3-phosphocholine

1-(1Z-hexadecenyl)-2-(9Z-hexadecenoyl)-sn-glycero-3-phosphocholine

C40H78NO7P (715.5515607999998)


A 1-(Z)-alk-1-enyl-2-acyl-sn-glycero-3-phosphocholine in which the alk-1-enyl and acyl groups are specified as (1Z)-hexadecenyl and (9Z)-hexadecenoyl respectively.

   

Hex1Cer(34:1)

Hex1Cer(d18:1_16:0(1+O))

C40H77NO9 (715.5598032)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

MePC(31:2)

MePC(16:2(1)_15:0)

C40H78NO7P (715.5515607999998)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

Hex1Cer(35:0)

Hex1Cer(d18:0_17:0)

C41H81NO8 (715.5961866)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

GalCer 14:0;O2/20:1;O

GalCer 14:0;O2/20:1;O

C40H77NO9 (715.5598032)


   

GalCer 14:0;O2/21:0

GalCer 14:0;O2/21:0

C41H81NO8 (715.5961866)


   

GalCer 14:0;O3/20:1

GalCer 14:0;O3/20:1

C40H77NO9 (715.5598032)


   

GalCer 14:1;O2/20:0;O

GalCer 14:1;O2/20:0;O

C40H77NO9 (715.5598032)


   

GalCer 15:0;O2/20:0

GalCer 15:0;O2/20:0

C41H81NO8 (715.5961866)


   

GalCer 15:1;O2/19:0;O

GalCer 15:1;O2/19:0;O

C40H77NO9 (715.5598032)


   

GalCer 16:0;O2/18:1;O

GalCer 16:0;O2/18:1;O

C40H77NO9 (715.5598032)


   

GalCer 16:0;O2/19:0

GalCer 16:0;O2/19:0

C41H81NO8 (715.5961866)


   

GalCer 16:0;O3/18:1

GalCer 16:0;O3/18:1

C40H77NO9 (715.5598032)


   

GalCer 16:1;O2/18:0;O

GalCer 16:1;O2/18:0;O

C40H77NO9 (715.5598032)


   

GalCer 17:0;O2/18:0

GalCer 17:0;O2/18:0

C41H81NO8 (715.5961866)


   

GalCer 17:0;O3/17:1

GalCer 17:0;O3/17:1

C40H77NO9 (715.5598032)


   

GalCer 17:1;O2/17:0;O

GalCer 17:1;O2/17:0;O

C40H77NO9 (715.5598032)


   

GalCer 18:0;O2/17:0

GalCer 18:0;O2/17:0

C41H81NO8 (715.5961866)


   

GalCer 18:0;O3/16:1

GalCer 18:0;O3/16:1

C40H77NO9 (715.5598032)


   

GalCer 18:1;O2/16:0;O

GalCer 18:1;O2/16:0;O

C40H77NO9 (715.5598032)


   

GalCer 19:0;O2/16:0

GalCer 19:0;O2/16:0

C41H81NO8 (715.5961866)


   

GalCer 19:0;O3/15:1

GalCer 19:0;O3/15:1

C40H77NO9 (715.5598032)


   

GalCer 19:1;O2/15:0;O

GalCer 19:1;O2/15:0;O

C40H77NO9 (715.5598032)


   

GalCer 20:0;O2/15:0

GalCer 20:0;O2/15:0

C41H81NO8 (715.5961866)


   

GalCer 20:0;O3/14:1

GalCer 20:0;O3/14:1

C40H77NO9 (715.5598032)


   

GalCer 20:1;O2/14:0;O

GalCer 20:1;O2/14:0;O

C40H77NO9 (715.5598032)


   

GalCer 21:0;O2/14:0

GalCer 21:0;O2/14:0

C41H81NO8 (715.5961866)


   

GalCer 21:1;O2/13:0;O

GalCer 21:1;O2/13:0;O

C40H77NO9 (715.5598032)


   

GalCer 22:0;O2/13:0

GalCer 22:0;O2/13:0

C41H81NO8 (715.5961866)


   

GalCer 22:1;O2/12:0;O

GalCer 22:1;O2/12:0;O

C40H77NO9 (715.5598032)


   
   
   
   

GlcCer 14:0;O2/20:1;O

GlcCer 14:0;O2/20:1;O

C40H77NO9 (715.5598032)


   

GlcCer 14:0;O2/21:0

GlcCer 14:0;O2/21:0

C41H81NO8 (715.5961866)


   

GlcCer 14:0;O3/20:1

GlcCer 14:0;O3/20:1

C40H77NO9 (715.5598032)


   

GlcCer 14:1;O2/20:0;O

GlcCer 14:1;O2/20:0;O

C40H77NO9 (715.5598032)


   

GlcCer 14:1;O2(4E)/20:0;O

GlcCer 14:1;O2(4E)/20:0;O

C40H77NO9 (715.5598032)


   

GlcCer 15:0;O2/20:0

GlcCer 15:0;O2/20:0

C41H81NO8 (715.5961866)


   

GlcCer 15:1;O2/19:0;O

GlcCer 15:1;O2/19:0;O

C40H77NO9 (715.5598032)


   

GlcCer 16:0;O2/18:1;O

GlcCer 16:0;O2/18:1;O

C40H77NO9 (715.5598032)


   

GlcCer 16:0;O2/19:0

GlcCer 16:0;O2/19:0

C41H81NO8 (715.5961866)


   

GlcCer 16:0;O3/18:1

GlcCer 16:0;O3/18:1

C40H77NO9 (715.5598032)


   

GlcCer 16:1;O2/18:0;O

GlcCer 16:1;O2/18:0;O

C40H77NO9 (715.5598032)


   

GlcCer 17:0;O2/18:0

GlcCer 17:0;O2/18:0

C41H81NO8 (715.5961866)


   

GlcCer 17:0;O3/17:1

GlcCer 17:0;O3/17:1

C40H77NO9 (715.5598032)


   

GlcCer 17:1;O2/17:0;O

GlcCer 17:1;O2/17:0;O

C40H77NO9 (715.5598032)


   

GlcCer 18:0;O2/17:0

GlcCer 18:0;O2/17:0

C41H81NO8 (715.5961866)


   

GlcCer 18:0;O3/16:1

GlcCer 18:0;O3/16:1

C40H77NO9 (715.5598032)


   

GlcCer 18:1;O2/16:0;O

GlcCer 18:1;O2/16:0;O

C40H77NO9 (715.5598032)


   

GlcCer 19:0;O2/16:0

GlcCer 19:0;O2/16:0

C41H81NO8 (715.5961866)


   

GlcCer 19:0;O3/15:1

GlcCer 19:0;O3/15:1

C40H77NO9 (715.5598032)


   

GlcCer 19:1;O2/15:0;O

GlcCer 19:1;O2/15:0;O

C40H77NO9 (715.5598032)


   

GlcCer 20:0;O2/15:0

GlcCer 20:0;O2/15:0

C41H81NO8 (715.5961866)


   

GlcCer 20:0;O3/14:1

GlcCer 20:0;O3/14:1

C40H77NO9 (715.5598032)


   

GlcCer 20:1;O2/14:0;O

GlcCer 20:1;O2/14:0;O

C40H77NO9 (715.5598032)


   

GlcCer 21:0;O2/14:0

GlcCer 21:0;O2/14:0

C41H81NO8 (715.5961866)


   

GlcCer 21:1;O2/13:0;O

GlcCer 21:1;O2/13:0;O

C40H77NO9 (715.5598032)


   

GlcCer 22:0;O2/13:0

GlcCer 22:0;O2/13:0

C41H81NO8 (715.5961866)


   

GlcCer 22:1;O2/12:0;O

GlcCer 22:1;O2/12:0;O

C40H77NO9 (715.5598032)


   
   
   
   

HexCer 14:0;O2/20:1;2OH

HexCer 14:0;O2/20:1;2OH

C40H77NO9 (715.5598032)


   

HexCer 14:0;O2/20:1;3OH

HexCer 14:0;O2/20:1;3OH

C40H77NO9 (715.5598032)


   

HexCer 14:0;O2/20:1;O

HexCer 14:0;O2/20:1;O

C40H77NO9 (715.5598032)


   

HexCer 14:0;O2/21:0

HexCer 14:0;O2/21:0

C41H81NO8 (715.5961866)


   

HexCer 14:0;O3/20:1

HexCer 14:0;O3/20:1

C40H77NO9 (715.5598032)


   

HexCer 14:1;O2/20:0;2OH

HexCer 14:1;O2/20:0;2OH

C40H77NO9 (715.5598032)


   

HexCer 14:1;O2/20:0;3OH

HexCer 14:1;O2/20:0;3OH

C40H77NO9 (715.5598032)


   

HexCer 14:1;O2/20:0;O

HexCer 14:1;O2/20:0;O

C40H77NO9 (715.5598032)


   

HexCer 15:0;O2/20:0

HexCer 15:0;O2/20:0

C41H81NO8 (715.5961866)


   

HexCer 15:1;O2/19:0;2OH

HexCer 15:1;O2/19:0;2OH

C40H77NO9 (715.5598032)


   

HexCer 15:1;O2/19:0;3OH

HexCer 15:1;O2/19:0;3OH

C40H77NO9 (715.5598032)


   

HexCer 15:1;O2/19:0;O

HexCer 15:1;O2/19:0;O

C40H77NO9 (715.5598032)


   

HexCer 16:0;O2/18:1;2OH

HexCer 16:0;O2/18:1;2OH

C40H77NO9 (715.5598032)


   

HexCer 16:0;O2/18:1;3OH

HexCer 16:0;O2/18:1;3OH

C40H77NO9 (715.5598032)


   

HexCer 16:0;O2/18:1;O

HexCer 16:0;O2/18:1;O

C40H77NO9 (715.5598032)


   

HexCer 16:0;O2/19:0

HexCer 16:0;O2/19:0

C41H81NO8 (715.5961866)


   

HexCer 16:0;O3/18:1

HexCer 16:0;O3/18:1

C40H77NO9 (715.5598032)


   

HexCer 16:1;O2/18:0;2OH

HexCer 16:1;O2/18:0;2OH

C40H77NO9 (715.5598032)


   

HexCer 16:1;O2/18:0;3OH

HexCer 16:1;O2/18:0;3OH

C40H77NO9 (715.5598032)


   

HexCer 16:1;O2/18:0;O

HexCer 16:1;O2/18:0;O

C40H77NO9 (715.5598032)


   

HexCer 17:0;O2/18:0

HexCer 17:0;O2/18:0

C41H81NO8 (715.5961866)


   

HexCer 17:0;O3/17:1

HexCer 17:0;O3/17:1

C40H77NO9 (715.5598032)


   

HexCer 17:1;O2/17:0;2OH

HexCer 17:1;O2/17:0;2OH

C40H77NO9 (715.5598032)


   

HexCer 17:1;O2/17:0;3OH

HexCer 17:1;O2/17:0;3OH

C40H77NO9 (715.5598032)


   

HexCer 17:1;O2/17:0;O

HexCer 17:1;O2/17:0;O

C40H77NO9 (715.5598032)


   

HexCer 18:0;O2/17:0

HexCer 18:0;O2/17:0

C41H81NO8 (715.5961866)


   

HexCer 18:0;O3/16:1

HexCer 18:0;O3/16:1

C40H77NO9 (715.5598032)


   

HexCer 18:1;O2/16:0;2OH

HexCer 18:1;O2/16:0;2OH

C40H77NO9 (715.5598032)


   

HexCer 18:1;O2/16:0;3OH

HexCer 18:1;O2/16:0;3OH

C40H77NO9 (715.5598032)


   

HexCer 18:1;O2/16:0;O

HexCer 18:1;O2/16:0;O

C40H77NO9 (715.5598032)


   

HexCer 19:0;O2/16:0

HexCer 19:0;O2/16:0

C41H81NO8 (715.5961866)


   

HexCer 19:0;O3/15:1

HexCer 19:0;O3/15:1

C40H77NO9 (715.5598032)


   

HexCer 19:1;O2/15:0;2OH

HexCer 19:1;O2/15:0;2OH

C40H77NO9 (715.5598032)


   

HexCer 19:1;O2/15:0;3OH

HexCer 19:1;O2/15:0;3OH

C40H77NO9 (715.5598032)


   

HexCer 19:1;O2/15:0;O

HexCer 19:1;O2/15:0;O

C40H77NO9 (715.5598032)


   

HexCer 20:0;O2/15:0

HexCer 20:0;O2/15:0

C41H81NO8 (715.5961866)


   

HexCer 20:0;O3/14:1

HexCer 20:0;O3/14:1

C40H77NO9 (715.5598032)


   

HexCer 20:1;O2/14:0;2OH

HexCer 20:1;O2/14:0;2OH

C40H77NO9 (715.5598032)


   

HexCer 20:1;O2/14:0;3OH

HexCer 20:1;O2/14:0;3OH

C40H77NO9 (715.5598032)


   

HexCer 20:1;O2/14:0;O

HexCer 20:1;O2/14:0;O

C40H77NO9 (715.5598032)


   

HexCer 21:0;O2/14:0

HexCer 21:0;O2/14:0

C41H81NO8 (715.5961866)


   

HexCer 21:1;O2/13:0;2OH

HexCer 21:1;O2/13:0;2OH

C40H77NO9 (715.5598032)


   

HexCer 21:1;O2/13:0;3OH

HexCer 21:1;O2/13:0;3OH

C40H77NO9 (715.5598032)


   

HexCer 21:1;O2/13:0;O

HexCer 21:1;O2/13:0;O

C40H77NO9 (715.5598032)


   

HexCer 22:0;O2/13:0

HexCer 22:0;O2/13:0

C41H81NO8 (715.5961866)


   

HexCer 22:1;O2/12:0;2OH

HexCer 22:1;O2/12:0;2OH

C40H77NO9 (715.5598032)


   

HexCer 22:1;O2/12:0;3OH

HexCer 22:1;O2/12:0;3OH

C40H77NO9 (715.5598032)


   

HexCer 22:1;O2/12:0;O

HexCer 22:1;O2/12:0;O

C40H77NO9 (715.5598032)